Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. Cancer. 2019 05 15; 125(10):1629-1636.
View in:
PubMed
subject areas
Academic Medical Centers
Adult
Age Factors
Aged
Antineoplastic Combined Chemotherapy Protocols
Biliary Tract Neoplasms
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Fluorouracil
Gastrointestinal Neoplasms
Genotype
Glucuronosyltransferase
Humans
Leucovorin
Male
Maximum Tolerated Dose
Middle Aged
Molecular Targeted Therapy
Pancreatic Neoplasms
Prognosis
Retrospective Studies
Risk Assessment
Sex Factors
Stomach Neoplasms
Survival Analysis
Treatment Outcome
authors with profiles
Mark Kozloff
Blase Polite
Theodore Karrison
Hedy Kindler